Even though microsatellite instability (MSI) tests or MMR tests have been used for ensuring endometrial cancer patients meet the criteria for ICIs following the molecular classification, we wondered if these agents could also be used as prognostic factors since PD-1 or PD-L1 inhibitors have been used for treatment. Here, CD274 is linked to endometrial cancer.